231 – 240 of 322
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
VWD type 3 - historical review and contemporary treatment dilemmas
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.111-111
- Contribution to journal › Published meeting abstract
-
Mark
Venous access - why such diverse experiences of central venous lines?
Stain, A M and Ljung, Rolf LU
(2008)
XXVIIIth International Congress of the World Federation of Hemophilia, 2008
In Haemophilia
14(s2).
p.96-96
- Contribution to journal › Published meeting abstract
-
Mark
Management of delivery and neonatal period
Ljung, Rolf LU
(2008)
XXVIIIth International Congress of the World Federation of Hemophilia, 2008
In Haemophilia
14(s2).
p.5-5
- Contribution to journal › Published meeting abstract
-
Mark
Musculoskeletal measurement tools from the International Prophylaxis Study Group (IPSG)
Feldman, B M ; Funk, S ; Lundin, Björn LU ; Doria, A S ; Ljung, Rolf LU
and Blanchette, V
(2008)
In Haemophilia
14(s3).
p.162-169
- Contribution to journal › Article
-
Mark
Asn1421Lys mutation in the glycoprotein Ib binding domain impairs - ristocetin and botrocetin - mediated binding of von Willebrand factor to platelets
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.116-116
- Contribution to journal › Published meeting abstract
-
Mark
Quality of life in haemophilia carriers - preliminary results of the ESCHQoL study
Tedgård, Ulf LU ; Ljung, Rolf LU
; Bullinger, M
and Von Mackensen, S
(2008)
XXVIIIth International Congress of the World Federation of Hemophilia, 2008
In Haemophilia
14(s2).
p.150-150
- Contribution to journal › Published meeting abstract
-
Mark
Thrombin generation assay: a useful tool in the management of haemophilia A patients?
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.26-26
- Contribution to journal › Published meeting abstract
-
Mark
Value added: increasing the power to assess treatment outcome in joint haemorrhages
- Contribution to journal › Article
-
Mark
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors
Hoots, W. K. ; Ebbesen, L. S. ; Konkle, B. A. ; Auerswald, G. K. -H. ; Roberts, H. R. ; Weatherall, J. ; Ferran, J. -M. ; Ljung, Rolf LU
; Bianco, R. Perez
and Ozelo, M. Castro
, et al.
(2008)
In Haemophilia
14(3).
p.466-466
- Contribution to journal › Article
-
Mark
Genetic aspects of inhibitor development
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.21-21
- Contribution to journal › Published meeting abstract